Pfizer Plant Threatened With Nationalisation

Nationalisation of a pharmaceutical company's mothballed production facility in Venezuela will have significant ramifications. Local manufacture of certain medicines will increase, thereby improving people's health and preserving precious foreign currency levels. However, BMI believes the socialist strategy will further discourage foreign direct investment, particularly the introduction of innovative pharmaceuticals over the medium term.

To read the full article, please choose one of the following options: